The Revello™ Vascular Covered Stent is designed to combine the flexibility of a nitinol self-expanding stent with the radial ...

Self-expanding polyethylene terephthalate and polytetrafluoroethylene (PTFE)-covered stents have been shown to decrease the need for repeat procedures in the iliac artery. [33] Similar to surgical ...

NATICK, Mass., Boston Scientific Corporation today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol ...

MOBILITY Trial Demonstrated Absolute Pro to be Safe and Effective in Patients with Peripheral Artery Disease in the Lower Extremities Abbott Park, Illinois — Abbott today announced that the U.S. Food ...

Please provide your email address to receive an email when new articles are posted on . Cordis announced the FDA has approved its self-expanding vascular stent designed for transradial peripheral ...

BD’s Revello Vascular Covered Stent receives CE marking to treat atherosclerotic lesions in common and external iliac arteries: Franklin Lakes, New Jersey Monday, March 9, 2026, ...

BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD ...

Boston Scientific Corp. has announced it has received FDA approval and market launch of its Epic vascular self-expanding stent system, according to a news release. Boston Scientific said the Epic ...

The aorta is the main blood vessel that carries oxygen-filled blood from the heart to the rest of the body. It extends from the chest to the abdomen, where it branches (bifurcates) into the iliac ...

BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system.